Investor FAQs

 

ChemoCentryx is traded on the NASDAQ global market under the symbol CCXI.
The CUSIP number is 16383L 106.
CCXI's initial public offering (IPO) occurred on February 8, 2012.

ChemoCentryx is incorporated in the state of Delaware.

ChemoCentryx, Inc.
850 Maude Avenue
Mountain View, California 94043

Shares can be purchased through any registered broker. ChemoCentryx does not have a direct stock purchase plan.

ChemoCentryx's fiscal year-end is December 31st.

American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219

Contact the transfer agent, American Stock Transfer & Trust Company. The transfer agent can look up your records and make any necessary adjustments. There may be a fee involved for replacing lost stock certificates

Ernst & Young LLP
275 Shoreline Drive, Suite 600
Redwood City, California 94065

Latham & Watkins LLP
12636 High Bluff Drive, Suite 400
San Diego, California 92130-2071

You may contact the ChemoCentryx investor relations department by email at ir@chemocentryx.com or by using the form below.

Please submit your question using the form below.

* Indicates required field